leisure time -WSS

leisure time

author：fashion 2025-10-01 12:25:31 - browse：8731

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Insmed lung disease drug hits target in key Phase 3 trial

hotspot

WSS

What will save rural psychiatry services? Higher Medicaid payments

Disclosing genetic information: not as worrisome as once feared

#NeedHerScience: shining a light on gender disparities in medicine

Cloning humans is technically possible. It's curious no one has tried

New guidelines on severe brain injury complicate already difficult decisions

3 hurdles to bringing medical devices to the U.S. market

focus

leisure time

hotspot

Drug repurposing or repositioning? The language matters

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Peter Hotez and the public health issue of online harassment

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Tori Bowie and the unacceptable rates of Black maternal death

First Opinion Podcast: What happens when kids become caregivers?

Novavax promises a turnaround & Lilly roils the obesity market

Prosthetic arm enables patients to feel the objects they grip

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Heat waves linked to early deliveries, preterm births in new study

focus

Addiction doctors spar with methadone clinics over legislation

Health insurers say they are turning to AI to cut costs, improve care

The science behind Janet Jackson's pregnancy at 49

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Average age of first period drops to 11.9 years, study shows

Why drug prescriptions should include diagnoses

explore

hotspot

entertainment

hotspot